<DOC>
	<DOCNO>NCT02413138</DOCNO>
	<brief_summary>The trial consist three stage : 1 ) 30 day Phase 2 PK PD evaluation somavaratan , 2 ) optional Phase 2 Extension 3 ) 12 month Phase 3 safety efficacy stage . Upon completion PK/PD stage , PK/PD profile GHD child study compare PK/PD profile GHD child treat Western study Phase 1b/2a study ( Protocol 12VR2 ) identify somavaratan dose use Phase 3 stage Japan . The Phase 3 stage continue dose 12 month obtain safety efficacy data 48 subject .</brief_summary>
	<brief_title>Versartis Trial Pre-pubertal Japanese Children With Growth Hormone Deficiency ( GHD ) Assess Long-Acting Growth Hormone ( Somavaratan , VRS-317 )</brief_title>
	<detailed_description>The trial consist three stage : 1 ) 30 day Phase 2 PK PD evaluation somavaratan , 2 ) optional Phase 2 Extension 3 ) 12 month Phase 3 safety efficacy stage . The study randomize , multi-center , open label study . The primary endpoint height velocity 12 month .</detailed_description>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Growth Disorders</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Chronological Age ≥ 3.0 year ≤ 9.0 year ( girl ) ≤ 10.0 year ( boy ) Prepubertal status Diagnosis GHD document two GH stimulation test result Height SD score ≤ 2.0 screen Weight Stature ≥ 10th percentile IGFI SD score ≤ 1.0 screen Delayed bone age Prior treatment growth promote agent History , current , significant disease Chromosomal aneuploidy , significant gene mutation ( cause GHD ) confirm diagnosis name syndrome Birth weight and/or birth length le 5th percentile gestational age A diagnosis Attention Deficit Hyperactivity Disorder Daily use antiinflammatory dos glucocorticoid Prior history leukemia , lymphoma , sarcoma cancer Ocular finding suggestive increase intracranial pressure and/or retinopathy screen Significant spinal abnormality include scoliosis , kyphosis spina bifida variant Significant abnormality screen laboratory study</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>GHD</keyword>
</DOC>